Skip to main content
Top
Published in: Archives of Virology 9/2016

01-09-2016 | Annotated Sequence Record

Senna leaf curl virus: a novel begomovirus identified in Senna occidentalis

Authors: Jitesh Kumar, Anshu Alok, Jitendra Kumar, Rakesh Tuli

Published in: Archives of Virology | Issue 9/2016

Login to get access

Abstract

Begomoviruses are whitefly-transmitted, single-stranded DNA viruses that infect a variety of cultivated (crop) and non-cultivated (weed) plants. The present study identified a novel begomovirus and satellites (alpha- and betasatellite) in Senna occidentalis (syn. Cassia occidentalis) showing leaf curl symptoms. The begomovirus shared a maximum sequence identity of 88.6 % with french bean leaf curl virus (JQ866297), whereas the alphasatellite and the betasatellite shared identities of 98 % and 90 % with ageratum yellow vein India alphasatellite (LK054802) and papaya leaf curl betasatellite (HM143906), respectively. No other begomovirus or satellites were detected in the suspected plants. We propose to name the virus “senna leaf curl virus” (SenLCuV).
Appendix
Available only for authorised users
Literature
6.
go back to reference Doyle JJ, Doyle JL (1987) A rapid DNA isolation procedure for small quantities of fresh leaf tissue. Phytochem bull 19:11–15 Doyle JJ, Doyle JL (1987) A rapid DNA isolation procedure for small quantities of fresh leaf tissue. Phytochem bull 19:11–15
9.
11.
Metadata
Title
Senna leaf curl virus: a novel begomovirus identified in Senna occidentalis
Authors
Jitesh Kumar
Anshu Alok
Jitendra Kumar
Rakesh Tuli
Publication date
01-09-2016
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 9/2016
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-016-2931-7

Other articles of this Issue 9/2016

Archives of Virology 9/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine